Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1735

1.

Brain tissue and myelin volumetric analysis in multiple sclerosis at 3T MRI with various in-plane resolutions using synthetic MRI.

Saccenti L, Andica C, Hagiwara A, Yokoyama K, Takemura MY, Fujita S, Maekawa T, Kamagata K, Le Berre A, Hori M, Hattori N, Aoki S.

Neuroradiology. 2019 Jun 18. doi: 10.1007/s00234-019-02241-w. [Epub ahead of print]

PMID:
31209528
2.

Efficacy of long-term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases: A multicenter, single-arm study.

Iozumi K, Abe M, Ito Y, Uesugi T, Onoduka T, Kato I, Kato F, Kodama K, Takahashi H, Takeda O, Tomizawa K, Nomiyama T, Fujii M, Mayama J, Muramoto F, Yasuda H, Yamanaka K, Sato T, Oh-I T, Kasai H, Tsuboi R, Hattori N, Maruyama R, Omi T, Shimoyama H, Sei Y, Nakasu I, Nishimoto S, Hata Y, Mochizuki T, Fukuzawa M, Seishima M, Sugiura K, Katayama I, Yamamoto O, Shindo M, Kiryu H, Kusuhara M, Takenaka M, Watanabe S.

J Dermatol. 2019 Jun 17. doi: 10.1111/1346-8138.14935. [Epub ahead of print]

PMID:
31206779
3.

Pneumatosis cystoides intestinalis in pulmonary mycobacterial disease.

Yamasaki M, Teshima H, Okanobu H, Hattori N.

Br J Hosp Med (Lond). 2019 Jun 2;80(6):iii. doi: 10.12968/hmed.2019.80.6.iii. No abstract available.

PMID:
31180773
4.

Deep brain stimulation shows high efficacy in two patients with GCH1 variants.

Daida K, Nishioka K, Shimo Y, Umemura A, Yoshino H, Hattori N.

Parkinsonism Relat Disord. 2019 Jun 3. pii: S1353-8020(19)30263-9. doi: 10.1016/j.parkreldis.2019.06.002. [Epub ahead of print] No abstract available.

PMID:
31178337
5.

Parkinson's disease in the Western Pacific Region.

Lim SY, Tan AH, Ahmad-Annuar A, Klein C, Tan LCS, Rosales RL, Bhidayasiri R, Wu YR, Shang HF, Evans AH, Pal PK, Hattori N, Tan CT, Jeon B, Tan EK, Lang AE.

Lancet Neurol. 2019 Jun 4. pii: S1474-4422(19)30195-4. doi: 10.1016/S1474-4422(19)30195-4. [Epub ahead of print] Review.

PMID:
31175000
6.

More subjects are required for ventrolateral than dorsolateral prefrontal TMS because of intolerability and potential drop-out.

Han S, Ogawa A, Osada T, Suda A, Tanaka M, Nanjo H, Shimo Y, Hattori N, Konishi S.

PLoS One. 2019 Jun 3;14(6):e0217826. doi: 10.1371/journal.pone.0217826. eCollection 2019.

7.

A metabolic profile of polyamines in Parkinson's disease: a promising biomarker.

Saiki S, Sasazawa Y, Fujimaki M, Kamagata K, Kaga N, Taka H, Li Y, Souma S, Hatano T, Imamichi Y, Furuya N, Mori A, Oji Y, Ueno SI, Nojiri S, Miura Y, Ueno T, Funayama M, Aoki S, Hattori N.

Ann Neurol. 2019 Jun 2. doi: 10.1002/ana.25516. [Epub ahead of print]

PMID:
31155745
8.

Gray Matter Alterations in Early and Late Relapsing-Remitting Multiple Sclerosis Evaluated with Synthetic Quantitative Magnetic Resonance Imaging.

Andica C, Hagiwara A, Kamagata K, Yokoyama K, Shimoji K, Saito A, Takenaka Y, Nakazawa M, Hori M, Cohen-Adad J, Takemura MY, Hattori N, Aoki S.

Sci Rep. 2019 May 31;9(1):8147. doi: 10.1038/s41598-019-44615-3.

9.

Neuromelanin or DaT-SPECT: which is the better marker for discriminating advanced Parkinson's disease?

Okuzumi A, Hatano T, Kamagata K, Hori M, Mori A, Oji Y, Taniguchi D, Daida K, Shimo Y, Yanagisawa N, Nojiri S, Aoki S, Hattori N.

Eur J Neurol. 2019 May 28. doi: 10.1111/ene.14009. [Epub ahead of print]

PMID:
31136060
10.

Cell-specific overexpression of COMT in dopaminergic neurons of Parkinson's disease.

Kuzumaki N, Suda Y, Iwasawa C, Narita M, Sone T, Watanabe M, Maekawa A, Matsumoto T, Akamatsu W, Igarashi K, Tamura H, Takeshima H, Tawfik VL, Ushijima T, Hattori N, Okano H, Narita M.

Brain. 2019 Jun 1;142(6):1675-1689. doi: 10.1093/brain/awz084.

PMID:
31135049
11.

Endobronchial Diffuse Large B-cell Lymphoma.

Yamasaki M, Matsumoto Y, Hattori N.

Arch Bronconeumol. 2019 May 22. pii: S0300-2896(19)30230-3. doi: 10.1016/j.arbres.2019.04.007. [Epub ahead of print] English, Spanish. No abstract available.

12.

Comparison of anti-aminoacyl-tRNA synthetase antibody-related and idiopathic non-specific interstitial pneumonia.

Shioya S, Masuda T, Yamaguchi K, Sakamoto S, Horimasu Y, Nakashima T, Miyamoto S, Senoo T, Iwamoto H, Ohshimo S, Fujitaka K, Hamada H, Hattori N.

Respir Med. 2019 Jun;152:44-50. doi: 10.1016/j.rmed.2019.04.023. Epub 2019 May 1.

PMID:
31128609
13.

Can cattle visually discriminate between green and dead forages at a short distance while moving in the field?

Hirata M, Arimoto C, Hattori N, Anzai H.

Anim Cogn. 2019 May 24. doi: 10.1007/s10071-019-01268-z. [Epub ahead of print]

PMID:
31127432
14.

Technique and outcome of percutaneous endoscopic transgastric jejunostomy for continuous infusion of levodopa-carbidopa intestinal gel for treatment of Parkinson's disease.

Ishibashi Y, Shimo Y, Yube Y, Oka S, Egawa H, Kohira Y, Kaji S, Kanda S, Oyama G, Hatano T, Hattori N, Fukunaga T.

Scand J Gastroenterol. 2019 May 24:1-6. doi: 10.1080/00365521.2019.1619830. [Epub ahead of print]

PMID:
31125265
15.

Acquired T790M-positive Squamous Cell Lung Carcinoma that Responded to Osimertinib.

Yamasaki M, Funaishi K, Daido W, Hattori N.

Arch Bronconeumol. 2019 May 20. pii: S0300-2896(19)30220-0. doi: 10.1016/j.arbres.2019.04.004. [Epub ahead of print] English, Spanish. No abstract available.

16.

Lambda Sign: Sarcoidosis.

Matsumoto Y, Yamasaki M, Matsumoto N, Taniwaki M, Hattori N.

Arch Bronconeumol. 2019 May 18. pii: S0300-2896(19)30119-X. doi: 10.1016/j.arbres.2019.03.008. [Epub ahead of print] English, Spanish. No abstract available.

17.

Role of B7H3/IL-33 Signaling in Pulmonary Fibrosis-induced Profibrogenic Alterations in Bone Marrow.

Nakashima T, Liu T, Hu B, Wu Z, Ullenbruch M, Omori K, Ding L, Hattori N, Phan SH.

Am J Respir Crit Care Med. 2019 May 18. doi: 10.1164/rccm.201808-1560OC. [Epub ahead of print]

PMID:
31106564
18.

Severe Metastatic Pulmonary Calcification.

Taniwaki M, Kawamoto K, Yamasaki M, Funaishi K, Matsumoto Y, Matsumoto N, Ohashi N, Hattori N.

Am J Med. 2019 May 15. pii: S0002-9343(19)30417-6. doi: 10.1016/j.amjmed.2019.04.031. [Epub ahead of print] No abstract available.

PMID:
31100282
19.

Increased lysosomal exocytosis induced by lysosomal Ca2+ channel agonists protects human dopaminergic neurons from α-synuclein toxicity.

Tsunemi T, Perez-Rosello T, Ishiguro Y, Yoroisaka A, Jeon S, Hamada K, Krishna Vangipuram Suresh M, Wong YC, Xie Z, Akamatsu W, Mazzulli JR, Surmeier DJ, Hattori N, Krainc D.

J Neurosci. 2019 May 16. pii: 3085-18. doi: 10.1523/JNEUROSCI.3085-18.2019. [Epub ahead of print]

PMID:
31097622
20.

Cancer cell niche factors secreted from cancer-associated fibroblast by loss of H3K27me3.

Maeda M, Takeshima H, Iida N, Hattori N, Yamashita S, Moro H, Yasukawa Y, Nishiyama K, Hashimoto T, Sekine S, Ishii G, Ochiai A, Fukagawa T, Katai H, Sakai Y, Ushijima T.

Gut. 2019 May 13. pii: gutjnl-2018-317645. doi: 10.1136/gutjnl-2018-317645. [Epub ahead of print]

PMID:
31085554
21.

Organization of functional modularity in sitting balance response and gait performance after stroke.

Yamasaki HR, An Q, Kinomoto M, Takahashi K, Fujii T, Kogami H, Yang N, Yamakawa H, Tamura Y, Itkonen M, Sonoo M, Alnajjar FSK, Yamashita A, Otomune H, Hattori N, Asama H, Miyai I, Shimoda S.

Clin Biomech (Bristol, Avon). 2019 May 3;67:61-69. doi: 10.1016/j.clinbiomech.2019.04.022. [Epub ahead of print]

PMID:
31075736
22.

Iron supply via NCOA4-mediated ferritin degradation maintains mitochondrial functions.

Fujimaki M, Furuya N, Saiki S, Amo T, Imamichi Y, Hattori N.

Mol Cell Biol. 2019 May 6. pii: MCB.00010-19. doi: 10.1128/MCB.00010-19. [Epub ahead of print]

PMID:
31061094
23.

Specific mechanisms of subarachnoid hemorrhage accompanied by ischemic stroke in essential thrombocythemia: two case reports and a literature review.

Sugiyama M, Ueno Y, Kamo H, Edahiro Y, Miyamoto N, Yamashiro K, Tanaka R, Shimo Y, Komatsu N, Hattori N.

J Neurol. 2019 May 2. doi: 10.1007/s00415-019-09347-4. [Epub ahead of print]

PMID:
31049728
24.

Long-Term Selegiline Monotherapy for the Treatment of Early Parkinson Disease.

Mizuno Y, Hattori N, Kondo T, Nomoto M, Origasa H, Takahashi R, Yamamoto M, Yanagisawa N.

Clin Neuropharmacol. 2019 Apr 30. doi: 10.1097/WNF.0000000000000343. [Epub ahead of print]

PMID:
31045589
25.

Tau aggregation and seeding analyses of two novel MAPT variants found in patients with motor neuron disease and progressive parkinsonism.

Nakayama S, Shimonaka S, Elahi M, Nishioka K, Oji Y, Matsumoto SE, Li Y, Yoshino H, Mogushi K, Hatano T, Sato T, Ikura T, Ito N, Motoi Y, Hattori N.

Neurobiol Aging. 2019 Mar 1. pii: S0197-4580(19)30066-1. doi: 10.1016/j.neurobiolaging.2019.02.016. [Epub ahead of print]

PMID:
31027853
26.
27.

Three-Component Repurposed Technology for Enhanced Expression: Highly Accumulable Transcriptional Activators via Branched Tag Arrays.

Kunii A, Hara Y, Takenaga M, Hattori N, Fukazawa T, Ushijima T, Yamamoto T, Sakuma T.

CRISPR J. 2018 Oct;1:337-347. doi: 10.1089/crispr.2018.0009.

PMID:
31021277
28.

Photochemical generation of the 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO) radical from caged nitroxides by near-infrared two-photon irradiation and its cytocidal effect on lung cancer cells.

Yamada A, Abe M, Nishimura Y, Ishizaka S, Namba M, Nakashima T, Shimoji K, Hattori N.

Beilstein J Org Chem. 2019 Apr 10;15:863-873. doi: 10.3762/bjoc.15.84. eCollection 2019.

29.

Corticosteroid therapy for organizing pneumonia in a human T-cell lymphotropic virus type-1 carrier.

Taniwaki M, Yamasaki M, Matsumoto Y, Matsumoto N, Ohashi N, Hattori N.

Pulmonology. 2019 May - Jun;25(3):193-195. doi: 10.1016/j.pulmoe.2019.02.004. Epub 2019 Apr 15. No abstract available.

30.

Involvement of cortical dysfunction in frequent falls in patients with Parkinson's disease.

Otomune H, Mihara M, Hattori N, Fujimoto H, Kajiyama Y, Konaka K, Mitani Y, Watanabe Y, Mochizuki H.

Parkinsonism Relat Disord. 2019 Apr 11. pii: S1353-8020(19)30202-0. doi: 10.1016/j.parkreldis.2019.04.007. [Epub ahead of print]

PMID:
30992233
31.

Bilateral thigh compartment syndromes from extended sitting with forward bending.

Shimada T, Tsunemi T, Hattori A, Nakazato-Taniguchi T, Yasuhara H, Ogaki K, Hattori N.

J Clin Neurosci. 2019 Jun;64:35-37. doi: 10.1016/j.jocn.2019.03.027. Epub 2019 Apr 6.

PMID:
30967313
32.

Multi-year whole-blood transcriptome data for the study of onset and progression of Parkinson's Disease.

Valentine MNZ, Hashimoto K, Fukuhara T, Saiki S, Ishikawa KI, Hattori N, Carninci P.

Sci Data. 2019 Apr 5;6(1):20. doi: 10.1038/s41597-019-0022-9.

33.

Postural Abnormality in Parkinson's Disease: A Large Comparative Study With General Population.

Ando Y, Fujimoto KI, Ikeda K, Utsumi H, Okuma Y, Oka H, Kamei S, Kurita A, Takahashi K, Nogawa S, Hattori N, Hirata K, Fukui T, Yamazaki K, Yamamoto T, Yoshii F.

Mov Disord Clin Pract. 2019 Jan 25;6(3):213-221. doi: 10.1002/mdc3.12723. eCollection 2019 Mar.

PMID:
30949552
34.

Suplatast tosilate reduces radiation-induced lung injury in mice through suppression of oxidative stress.

Izumi Y, Nakashima T, Masuda T, Shioya S, Fukuhara K, Yamaguchi K, Sakamoto S, Horimasu Y, Miyamoto S, Iwamoto H, Fujitaka K, Hamada H, Hattori N.

Free Radic Biol Med. 2019 May 20;136:52-59. doi: 10.1016/j.freeradbiomed.2019.03.024. Epub 2019 Mar 28.

PMID:
30930296
35.

Large aortic arch plaques correlate with CHADS2 and CHA2DS2-VASc scores in cryptogenic stroke.

Ueno Y, Tateishi Y, Doijiri R, Kuriki A, Shimizu T, Kikuno M, Shimada Y, Takekawa H, Yamaguchi E, Koga M, Kamiya Y, Ihara M, Tsujino A, Hirata K, Toyoda K, Hasegawa Y, Hattori N, Urabe T.

Atherosclerosis. 2019 May;284:181-186. doi: 10.1016/j.atherosclerosis.2019.03.009. Epub 2019 Mar 20.

PMID:
30921601
36.

LINC00162 confers sensitivity to 5-Aza-2'-deoxycytidine via modulation of an RNA splicing protein, HNRNPH1.

Zong L, Hattori N, Yasukawa Y, Kimura K, Mori A, Seto Y, Ushijima T.

Oncogene. 2019 Mar 26. doi: 10.1038/s41388-019-0792-8. [Epub ahead of print]

PMID:
30914798
37.

Metabolomics-based identification of metabolic alterations in PARK2.

Okuzumi A, Hatano T, Ueno SI, Ogawa T, Saiki S, Mori A, Koinuma T, Oji Y, Ishikawa KI, Fujimaki M, Sato S, Ramamoorthy S, Mohney RP, Hattori N.

Ann Clin Transl Neurol. 2019 Feb 21;6(3):525-536. doi: 10.1002/acn3.724. eCollection 2019 Mar.

38.

Alteration of gut microbiota by a Westernized lifestyle and its correlation with insulin resistance in non-diabetic Japanese men.

Yamashita M, Okubo H, Kobuke K, Ohno H, Oki K, Yoneda M, Tanaka J, Hattori N.

J Diabetes Investig. 2019 Mar 22. doi: 10.1111/jdi.13048. [Epub ahead of print]

39.

Cerebral embolism during edoxaban administration for venous thromboembolism in a patient with lung adenocarcinoma: A case report.

Nakao S, Masuda T, Sakamoto S, Yamaguchi K, Horimasu Y, Miyamoto S, Nakashima T, Iwamoto H, Fujitaka K, Hamada H, Hattori N.

Medicine (Baltimore). 2019 Mar;98(12):e14821. doi: 10.1097/MD.0000000000014821.

40.

Endobronchial mucosa-associated lymphoid tissue (MALT) lymphoma.

Yamasaki M, Funaishi K, Muta T, Matsumoto N, Taniwaki M, Hattori N.

QJM. 2019 Mar 21. pii: hcz069. doi: 10.1093/qjmed/hcz069. [Epub ahead of print] No abstract available.

PMID:
30895318
41.

The Effects of Astrocyte and Oligodendrocyte Lineage Cell Interaction on White Matter Injury under Chronic Cerebral Hypoperfusion.

Magami S, Miyamoto N, Ueno Y, Hira K, Tanaka R, Yamashiro K, Oishi H, Arai H, Urabe T, Hattori N.

Neuroscience. 2019 May 15;406:167-175. doi: 10.1016/j.neuroscience.2019.03.004. Epub 2019 Mar 10.

PMID:
30867131
42.

Impact of CD123 expression, analyzed by immunohistochemistry, on clinical outcomes in patients with acute myeloid leukemia.

Arai N, Homma M, Abe M, Baba Y, Murai S, Watanuki M, Kawaguchi Y, Fujiwara S, Kabasawa N, Tsukamoto H, Uto Y, Ariizumi H, Yanagisawa K, Hattori N, Saito B, Shiozawa E, Harada H, Yamochi-Onizuka T, Nakamaki T, Takimoto M.

Int J Hematol. 2019 May;109(5):539-544. doi: 10.1007/s12185-019-02616-y. Epub 2019 Mar 7.

PMID:
30847774
43.

Parkinsonism relating to intoxication with glyphosate: A case report.

Eriguchi M, Iida K, Ikeda S, Osoegawa M, Nishioka K, Hattori N, Nagayama H, Hara H.

Intern Med. 2019 Feb 25. doi: 10.2169/internalmedicine.2028-18. [Epub ahead of print]

44.

Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.

Imai Y, Meng H, Shiba-Fukushima K, Hattori N.

Int J Mol Sci. 2019 Feb 20;20(4). pii: E908. doi: 10.3390/ijms20040908. Review.

45.

Establishing extracorporeal membrane oxygenation team increased number of patients and improved data recording.

Komindr A, Abe R, Tateishi Y, Takahashi Y, Goto J, Wada K, Furukawa Y, Sugiura A, Imaeda T, Suga N, Hattori N, Oda S.

J Intensive Care. 2019 Feb 7;7:11. doi: 10.1186/s40560-019-0366-4. eCollection 2019.

46.

Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features.

Ikeda A, Shimada H, Nishioka K, Takanashi M, Hayashida A, Li Y, Yoshino H, Funayama M, Ueno Y, Hatano T, Sahara N, Suhara T, Higuchi M, Hattori N.

Mov Disord. 2019 Apr;34(4):568-574. doi: 10.1002/mds.27623. Epub 2019 Feb 17.

PMID:
30773680
47.

Pontine hemorrhage accompanied by neuromyelitis optica spectrum disorder.

Kamo H, Ueno Y, Sugiyama M, Miyamoto N, Yamashiro K, Tanaka R, Yokoyama K, Hattori N.

J Neuroimmunol. 2019 May 15;330:19-22. doi: 10.1016/j.jneuroim.2019.01.020. Epub 2019 Feb 1.

PMID:
30769213
48.

Acquired factor V inhibitor after antibiotic treatment in a patient with pneumonia: a case report.

Taniwaki M, Katsutani S, Yamasaki M, Kawamoto K, Funaishi K, Matsumoto Y, Matsumoto N, Ohashi N, Hattori N.

Ann Hematol. 2019 Feb 12. doi: 10.1007/s00277-019-03638-6. [Epub ahead of print] No abstract available.

PMID:
30747247
49.

Adjuvant and antigenic properties of Mycobacterium avium subsp. paratuberculosis on experimental autoimmune encephalomyelitis.

Cossu D, Yokoyama K, Sakanishi T, Momotani E, Hattori N.

J Neuroimmunol. 2019 May 15;330:174-177. doi: 10.1016/j.jneuroim.2019.01.013. Epub 2019 Jan 23.

PMID:
30738572
50.

Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblasts.

Masuda T, Nakashima T, Namba M, Yamaguchi K, Sakamoto S, Horimasu Y, Miyamoto S, Iwamoto H, Fujitaka K, Miyata Y, Hamada H, Okada M, Hattori N.

J Cell Mol Med. 2019 Apr;23(4):2984-2994. doi: 10.1111/jcmm.14205. Epub 2019 Feb 7.

Supplemental Content

Loading ...
Support Center